Market Tracker

03/23 7:56am ET

Bristol-Myers Squibb Co (NYSE:BMY)

56.36
Delayed Data
As of Mar 22
 +0.65 / +1.17%
Today’s Change
46.01
Today|||52-Week Range
77.12
-3.56%
Year-to-Date
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference
Mar 20 / TheStreet.com - Paid Partner Content
Bristol-Myers Squibb and CytomX Therapeutics Extend Deal
Mar 21 / Zacks.com - Paid Partner Content
CytomX Soars on Bristol-Myers Partnership
Mar 20 / TheStreet.com - Paid Partner Content
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017
Mar 21 / Zacks.com - Paid Partner Content
Stock Futures Slip After G20 Meeting Raises Fears of Protectionism
Mar 20 / TheStreet.com - Paid Partner Content
Dodge & Cox Buys Bristol-Myers Squibb Company, Zayo Group Holdings, Medtronic PLC, Se...
Mar 20 / GuruFocus News - Paid Partner Content
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
Mar 20 / TheStreet.com - Paid Partner Content
Stocks Lower as Crude Slump Weighs on Energy Sector
Mar 20 / TheStreet.com - Paid Partner Content
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close55.71
Today’s open55.70
Day’s range55.17 - 56.42
Volume9,808,349
Average volume (3 months)12,151,946
Market cap$94.3B
Dividend yield2.77%
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+184.95%
Earnings growth (this year)-0.84%
Earnings growth (next 5 years)+17.65%
Revenue growth (last year)+17.31%
P/E ratio21.3
Price/Sales5.05
Price/Book5.80

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.63+0.75%
CELGCelgene-0.45-0.36%
GSKGlaxoSmithKline-0.04-0.09%
ABBVAbbVie+0.17+0.26%
Data as of 03/22/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$0.73
Annual revenue (last year)$19.4B
Annual profit (last year)$4.5B
Net profit margin22.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts